Skip to main content
Top
Published in: Diabetologia 5/2013

01-05-2013 | Article

Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models

Authors: M. K.-H. Schäfer, N. R. Hartwig, N. Kalmbach, M. Klietz, M. Anlauf, L. E. Eiden, E. Weihe

Published in: Diabetologia | Issue 5/2013

Login to get access

Abstract

Aims/hypothesis

Imaging of beta cell mass (BCM) is a major challenge in diabetes research. The vesicular monoamine transporter 2 (VMAT2) is abundantly expressed in human beta cells. Radiolabelled analogues of tetrabenazine (TBZ; a low-molecular-weight, cell-permeant VMAT2-selective ligand) have been employed for pancreatic islet imaging in humans. Since reports on TBZ-based VMAT2 imaging in rodent pancreas have been fraught with confusion, we compared VMAT2 gene expression patterns in the mouse, rat, pig and human pancreas, to identify appropriate animal models with which to further validate and optimise TBZ imaging in humans.

Methods

We used a panel of highly sensitive VMAT2 antibodies developed against equivalently antigenic regions of the transporter from each species in combination with immunostaining for insulin and species-specific in situ hybridisation probes. Individual pancreatic islets were obtained by laser-capture microdissection and subjected to analysis of mRNA expression of VMAT2.

Results

The VMAT2 protein was not expressed in beta cells in the adult pancreas of common mouse or rat laboratory strains, in contrast to its expression in beta cells (but not other pancreatic endocrine cell types) in the pancreas of pigs and humans. VMAT2- and tyrosine hydroxylase co-positive (catecholaminergic) innervation was less abundant in humans than in rodents. VMAT2-positive mast cells were identified in the pancreas of all species.

Conclusions/interpretation

Primates and pigs are suitable models for TBZ imaging of beta cells. Rodents, because of a complete lack of VMAT2 expression in the endocrine pancreas, are a ‘null’ model for assessing interference with BCM measurements by VMAT2-positive mast cells and sympathetic innervation in the pancreas.
Appendix
Available only for authorised users
Literature
1.
go back to reference Weihe E, Schafer MK, Erickson JD, Eiden LE (1994) Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J Mol Neurosci 5:149–164PubMedCrossRef Weihe E, Schafer MK, Erickson JD, Eiden LE (1994) Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J Mol Neurosci 5:149–164PubMedCrossRef
2.
go back to reference Peter D, Liu Y, Sternini C, de Giorgio R, Brecha N, Edwards RH (1995) Differential expression of two vesicular monoamine transporters. J Neurosci 15:6179–6188PubMed Peter D, Liu Y, Sternini C, de Giorgio R, Brecha N, Edwards RH (1995) Differential expression of two vesicular monoamine transporters. J Neurosci 15:6179–6188PubMed
3.
go back to reference Erickson JD, Schäfer MK-H, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166–5171PubMedCrossRef Erickson JD, Schäfer MK-H, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166–5171PubMedCrossRef
4.
go back to reference Eiden LE, Weihe E (2011) VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann N Y Acad Sci 1216:86–98PubMedCrossRef Eiden LE, Weihe E (2011) VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann N Y Acad Sci 1216:86–98PubMedCrossRef
5.
go back to reference Eiden LE (2000) The vesicular neurotransmitter transporters: current perspectives and future prospects. FASEB J 14:2396–2400PubMedCrossRef Eiden LE (2000) The vesicular neurotransmitter transporters: current perspectives and future prospects. FASEB J 14:2396–2400PubMedCrossRef
6.
go back to reference Weihe E, Eiden LE (2000) Chemical neuroanatomy of the vesicular amine transporters. FASEB J 14:2435–2449PubMedCrossRef Weihe E, Eiden LE (2000) Chemical neuroanatomy of the vesicular amine transporters. FASEB J 14:2435–2449PubMedCrossRef
7.
go back to reference Howell M, Shirvan A, Stern-Bach Y et al (1994) Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules. FEBS Lett 338:16–22PubMedCrossRef Howell M, Shirvan A, Stern-Bach Y et al (1994) Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules. FEBS Lett 338:16–22PubMedCrossRef
8.
go back to reference Krejjci E, Gasnier B, Botton D et al (1993) Expression and regulation of the bovine vesicular monoamine transporter gene. FEBS Lett 335:27–32CrossRef Krejjci E, Gasnier B, Botton D et al (1993) Expression and regulation of the bovine vesicular monoamine transporter gene. FEBS Lett 335:27–32CrossRef
9.
go back to reference Eiden LE, Schafer MK, Weihe E, Schutz B (2004) The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine. Pflugers Arch 447:636–640PubMedCrossRef Eiden LE, Schafer MK, Weihe E, Schutz B (2004) The vesicular amine transporter family (SLC18): amine/proton antiporters required for vesicular accumulation and regulated exocytotic secretion of monoamines and acetylcholine. Pflugers Arch 447:636–640PubMedCrossRef
10.
go back to reference Anlauf M, Eissele R, Schafer MK et al (2003) Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors. J Histochem Cytochem 51:1027–1040PubMedCrossRef Anlauf M, Eissele R, Schafer MK et al (2003) Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors. J Histochem Cytochem 51:1027–1040PubMedCrossRef
11.
go back to reference Saisho Y, Harris PE, Butler AE et al (2008) Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. J Mol Histol 39:543–551PubMedCrossRef Saisho Y, Harris PE, Butler AE et al (2008) Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. J Mol Histol 39:543–551PubMedCrossRef
12.
go back to reference Maffei A, Liu Z, Witkowski P et al (2004) Identification of tissue-restricted transcripts in human islets. Endocrinology 145:4513–4521PubMedCrossRef Maffei A, Liu Z, Witkowski P et al (2004) Identification of tissue-restricted transcripts in human islets. Endocrinology 145:4513–4521PubMedCrossRef
13.
go back to reference Kung HF, Lieberman BP, Zhuang ZP et al (2008) In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine. Nucl Med Biol 35:825–837PubMedCrossRef Kung HF, Lieberman BP, Zhuang ZP et al (2008) In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine. Nucl Med Biol 35:825–837PubMedCrossRef
14.
go back to reference Freeby M, Goland R, Ichise M, Maffei A, Leibel R, Harris P (2008) VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease. Diabetes Obes Metab 10(suppl 4):98–108PubMedCrossRef Freeby M, Goland R, Ichise M, Maffei A, Leibel R, Harris P (2008) VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease. Diabetes Obes Metab 10(suppl 4):98–108PubMedCrossRef
15.
go back to reference Simpson NR, Souza F, Witkowski P et al (2006) Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nucl Med Biol 33:855–864PubMedCrossRef Simpson NR, Souza F, Witkowski P et al (2006) Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nucl Med Biol 33:855–864PubMedCrossRef
16.
go back to reference Normandin MD, Petersen KF, Ding YS et al (2012) In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 53:908–916PubMedCrossRef Normandin MD, Petersen KF, Ding YS et al (2012) In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 53:908–916PubMedCrossRef
17.
go back to reference Bohnen NI, Albin RL, Koeppe RA et al (2006) Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab 26:1198–1212PubMed Bohnen NI, Albin RL, Koeppe RA et al (2006) Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab 26:1198–1212PubMed
18.
go back to reference Frey KA, Koeppe RA, Kilbourn MR et al (1996) Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 40:873–884PubMedCrossRef Frey KA, Koeppe RA, Kilbourn MR et al (1996) Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 40:873–884PubMedCrossRef
19.
go back to reference Boileau I, Rusjan P, Houle S et al (2008) Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: is VMAT2 a stable dopamine neuron biomarker? J Neurosci 28:9850–9856PubMedCrossRef Boileau I, Rusjan P, Houle S et al (2008) Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: is VMAT2 a stable dopamine neuron biomarker? J Neurosci 28:9850–9856PubMedCrossRef
20.
go back to reference Fagerholm V, Mikkola KK, Ishizu T et al (2010) Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med 51:1439–1446PubMedCrossRef Fagerholm V, Mikkola KK, Ishizu T et al (2010) Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med 51:1439–1446PubMedCrossRef
21.
go back to reference Souza F, Freeby M, Hultman K et al (2006) Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas. Curr Med Chem 13:2761–2773PubMedCrossRef Souza F, Freeby M, Hultman K et al (2006) Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas. Curr Med Chem 13:2761–2773PubMedCrossRef
22.
23.
go back to reference Lin KJ, Weng YH, Wey SP et al (2010) Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent. J Nucl Med 51:1480–1485PubMedCrossRef Lin KJ, Weng YH, Wey SP et al (2010) Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent. J Nucl Med 51:1480–1485PubMedCrossRef
24.
go back to reference Eriksson O, Jahan M, Johnström P et al (2010) In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass. Nucl Med Biol 37:357–363PubMedCrossRef Eriksson O, Jahan M, Johnström P et al (2010) In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass. Nucl Med Biol 37:357–363PubMedCrossRef
25.
26.
go back to reference Harris PE, Ferrara C, Barba P, Polito T, Freeby M, Maffei A (2008) VMAT2 gene expression and function as it applies to imaging beta-cell mass. J Mol Med (Berl) 86:5–16CrossRef Harris PE, Ferrara C, Barba P, Polito T, Freeby M, Maffei A (2008) VMAT2 gene expression and function as it applies to imaging beta-cell mass. J Mol Med (Berl) 86:5–16CrossRef
27.
go back to reference Kilbourn MR (2010) Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers. Nucl Med Biol 37:869–871PubMedCrossRef Kilbourn MR (2010) Rat pancreas uptake of [11C]dihydrotetrabenazine stereoisomers. Nucl Med Biol 37:869–871PubMedCrossRef
28.
go back to reference Virostko J, Henske J, Vinet L et al (2011) Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proc Natl Acad Sci U S A 108:20719–20724PubMedCrossRef Virostko J, Henske J, Vinet L et al (2011) Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proc Natl Acad Sci U S A 108:20719–20724PubMedCrossRef
29.
go back to reference Cline GW, Zhao X, Jakowski AB, Soeller WC, Treadway JL (2011) Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic beta-cell mass. Biochem Biophys Res Commun 412:413–418PubMedCrossRef Cline GW, Zhao X, Jakowski AB, Soeller WC, Treadway JL (2011) Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic beta-cell mass. Biochem Biophys Res Commun 412:413–418PubMedCrossRef
30.
go back to reference Marselli L, Thorne J, Ahn YB et al (2008) Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 93:1046–1053PubMedCrossRef Marselli L, Thorne J, Ahn YB et al (2008) Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab 93:1046–1053PubMedCrossRef
31.
go back to reference Bender FL, Mederos YSM, Li Y et al (2005) The temperature-sensitive ion channel TRPV2 is endogenously expressed and functional in the primary sensory cell line F-11. Cell Physiol Biochem 15:183–194PubMedCrossRef Bender FL, Mederos YSM, Li Y et al (2005) The temperature-sensitive ion channel TRPV2 is endogenously expressed and functional in the primary sensory cell line F-11. Cell Physiol Biochem 15:183–194PubMedCrossRef
32.
go back to reference Erickson JD, Eiden LE, Hoffman B (1992) Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA 89:10993–10997PubMedCrossRef Erickson JD, Eiden LE, Hoffman B (1992) Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA 89:10993–10997PubMedCrossRef
33.
go back to reference Schafer MK-H, Day R (1995) In situ hybridization histochemistry. Meth Neurosci 23:16–44CrossRef Schafer MK-H, Day R (1995) In situ hybridization histochemistry. Meth Neurosci 23:16–44CrossRef
34.
go back to reference Weihe E, Schutz B, Hartschuh W, Anlauf M, Schafer MK, Eiden LE (2005) Co-expression of cholinergic and noradrenergic phenotypes in human and non-human autonomic nervous system. J Comp Neurol 492:370–379PubMedCrossRef Weihe E, Schutz B, Hartschuh W, Anlauf M, Schafer MK, Eiden LE (2005) Co-expression of cholinergic and noradrenergic phenotypes in human and non-human autonomic nervous system. J Comp Neurol 492:370–379PubMedCrossRef
35.
go back to reference Kilbourn MR, Hockley B, Lee L et al (2007) Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain. Nucl Med Biol 34:233–237PubMedCrossRef Kilbourn MR, Hockley B, Lee L et al (2007) Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain. Nucl Med Biol 34:233–237PubMedCrossRef
36.
go back to reference Ichise M, Vines DC, Gura T et al (2006) Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J Neurosci 26:4638–4643PubMedCrossRef Ichise M, Vines DC, Gura T et al (2006) Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J Neurosci 26:4638–4643PubMedCrossRef
Metadata
Title
Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models
Authors
M. K.-H. Schäfer
N. R. Hartwig
N. Kalmbach
M. Klietz
M. Anlauf
L. E. Eiden
E. Weihe
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2847-7

Other articles of this Issue 5/2013

Diabetologia 5/2013 Go to the issue